Lilly Trials
The SELECT trial with semaglutide 2.4 mg demonstrated a 20% reduction in MACE among patients with established cardiovascular disease and overweight or obesity, even in those without diabetes
Shares of Hims & Hers, an online health and wellness company that sells compounded GLP-1 medications, plummeted 25% on Friday
In conclusion, as we witness the evolving landscape of obesity management, GLP-1 agonists stand tall as potent allies in fostering weight loss and promoting holistic well-being
How does Semaglutide GLP-1 help regulate appetite for weight loss
These may have ingredients like berberine, cinnamon, garcinia, etc., which claim to help manage appetite, reduce insulin resistance, manage blood sugar levels and support overall wellness 9 , 10 , 12